3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
44
Triple Negative Breast Neoplasms
20
Breast Neoplasms
16
Carcinoma, Non-Small-Cell Lung
14
Neoplasm Metastasis
10
Lung Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
8
Parkinson Disease 4, Autosomal Dominant Lewy Body
7
Neoplasms
6
Adenocarcinoma
6
Cholangiocarcinoma
5
Stomach Neoplasms
4
Gallbladder Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Esophageal Neoplasms
4
Biliary Tract Neoplasms
4
Uterine Cervical Neoplasms
3
Recurrence
3
Pancreatic Adenocarcinoma
3
Ovarian Neoplasms
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Endometrial Neoplasms
3
Colorectal Neoplasms
3
Small Cell Lung Carcinoma
2
Sarcoma
2
Rectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Pancreatic Ductal
2
Carcinoma, Hepatocellular
2
Interventions
pembrolizumab
6
Cetuximab
5
olaparib
3
atezolizumab
3
Injections
3
fludarabine
2
Trastuzumab
2
Docetaxel
2
Cyclophosphamide
2
Bevacizumab
2
zolbetuximab
1
zimberelimab
1
zansecimab
1
tocilizumab
1
taxane
1
spartalizumab
1
somatostatin receptor 2
1
ribociclib
1
pralsetinib
1
pertuzumab
1
pegylated granulocyte colony-stimulating factor
1
lenvatinib
1
ipatasertib
1
inavolisib
1
fludarabine phosphate
1
entrectinib
1
encorafenib
1
durvalumab
1
dapagliflozin
1
cemiplimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumors
×
Albumin-Bound Paclitaxel
×
1 year
×
Clear all
No trials found.